FDA — authorised 18 February 1982
- Application: NDA017707
- Marketing authorisation holder: GE HEALTHCARE
- Local brand name: MPI INDIUM DTPA IN 111
- Indication: INJECTABLE — INTRATHECAL
- Status: approved
🇺🇸 MPI INDIUM DTPA IN 111 in United States
FDA authorised MPI INDIUM DTPA IN 111 on 18 February 1982
Marketing authorisations
FDA
- Status: approved
Other Other approved in United States
Frequently asked questions
Is MPI INDIUM DTPA IN 111 approved in United States?
Yes. FDA authorised it on 18 February 1982; FDA has authorised it.
Who is the marketing authorisation holder for MPI INDIUM DTPA IN 111 in United States?
GE HEALTHCARE holds the US marketing authorisation.